AVITA Medical, Inc.
RCEL
$7.51
-$0.30-3.84%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.59M | -16.21M | -15.39M | -18.66M | -7.07M |
| Total Depreciation and Amortization | 409.00K | 310.00K | 204.00K | 203.00K | 187.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 86.00K |
| Total Other Non-Cash Items | 3.85M | 6.32M | 2.46M | 3.84M | -4.07M |
| Change in Net Operating Assets | -746.00K | 2.36M | -51.00K | -6.25M | 3.00K |
| Cash from Operations | -8.08M | -7.21M | -12.78M | -20.86M | -10.86M |
| Capital Expenditure | -1.61M | -3.76M | -2.65M | -1.15M | -296.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.08M | 11.15M | 15.08M | 16.21M | -57.01M |
| Cash from Investing | 2.47M | 7.39M | 12.43M | 15.07M | -57.30M |
| Total Debt Issued | -- | -- | -- | -- | 38.76M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.02M | 1.01M | 849.00K | 631.00K | 670.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.02M | 1.01M | 849.00K | 631.00K | 39.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.59M | 1.19M | 501.00K | -5.17M | -28.74M |
